Search
Now showing items 1-10 of 108
When should the clinician suspect a drug-induced blood dyscrasia, and how should he proceed?
Beitrag zu einer Konferenz
(Universität Ulm, 1996)
Chronic myeloid leukemia in accelerated phase: treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patients
Wissenschaftlicher Artikel
(Universität Ulm, 1998)
Chronic myelogenous leukemia in blast crisis: Retrospective analysis of prognostic factors in 90 patients
Wissenschaftlicher Artikel
(Universität Ulm, 1996)
Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count
Wissenschaftlicher Artikel
(Universität Ulm, 1999)
Leukocyte transfusion for treatment of a chronic myeloid leukemia relapse following allogeneic bone marrow transplantation
Beitrag zu einer Konferenz
(Universität Ulm, 1994)
ROFERON (RIFN-ALPHA(2A)) IS MORE IMMUNOGENIC THAN INTRON-A (RIFN-ALPHA(2B)) IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
Beitrag zu einer Konferenz
(Universität Ulm, 1994)
MEASUREMENT OF RECIPIENT-SPECIFIC ALLOREACTIVITY - IS GVHD PREDICTABLE
Beitrag zu einer Konferenz
(Universität Ulm, 1993)
HOST-SPECIFIC INTERLEUKIN-2-SECRETING DONOR T-CELL PRECURSORS AS PREDICTORS OF ACUTE GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANTATION BETWEEN HLA-IDENTICAL SIBLINGS
Wissenschaftlicher Artikel
(Universität Ulm, 1992)
ANTILYMPHOCYTE IMMUNOGLOBULINS STIMULATE PERIPHERAL-BLOOD LYMPHOCYTES TO PROLIFERATE AND RELEASE LYMPHOKINES
Wissenschaftlicher Artikel
(Universität Ulm, 1990)